- Home
- EDIT vs BLNK Comparison
EDIT vs BLNK Comparison
Compare EDIT & BLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- BLNK
- Stock Information
- Founded
- EDIT 2013
- BLNK 2009
- Country
- EDIT United States
- BLNK United States
- Employees
- EDIT N/A
- BLNK N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- BLNK Industrial Specialties
- Sector
- EDIT Health Care
- BLNK Consumer Discretionary
- Exchange
- EDIT Nasdaq
- BLNK Nasdaq
- Market Cap
- EDIT 108.1M
- BLNK 105.2M
- IPO Year
- EDIT 2016
- BLNK N/A
- Fundamental
- Price
- EDIT $1.25
- BLNK $0.94
- Analyst Decision
- EDIT Buy
- BLNK Buy
- Analyst Count
- EDIT 14
- BLNK 8
- Target Price
- EDIT $8.08
- BLNK $3.31
- AVG Volume (30 Days)
- EDIT 2.5M
- BLNK 3.9M
- Earning Date
- EDIT 03-05-2025
- BLNK 03-13-2025
- Dividend Yield
- EDIT N/A
- BLNK N/A
- EPS Growth
- EDIT N/A
- BLNK N/A
- EPS
- EDIT N/A
- BLNK N/A
- Revenue
- EDIT $32,314,000.00
- BLNK $126,197,000.00
- Revenue This Year
- EDIT N/A
- BLNK $25.90
- Revenue Next Year
- EDIT N/A
- BLNK $35.81
- P/E Ratio
- EDIT N/A
- BLNK N/A
- Revenue Growth
- EDIT N/A
- BLNK N/A
- 52 Week Low
- EDIT $1.12
- BLNK $0.87
- 52 Week High
- EDIT $7.41
- BLNK $3.75
- Technical
- Relative Strength Index (RSI)
- EDIT 41.70
- BLNK 41.47
- Support Level
- EDIT $1.24
- BLNK $0.98
- Resistance Level
- EDIT $1.32
- BLNK $1.05
- Average True Range (ATR)
- EDIT 0.11
- BLNK 0.07
- MACD
- EDIT -0.03
- BLNK 0.00
- Stochastic Oscillator
- EDIT 2.94
- BLNK 29.01
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns majority revenue from U.S.A.